Aspen Aerogels (ASPN) Common Equity (2013 - 2026)

Aspen Aerogels (ASPN) has reported Common Equity for 14 consecutive years, with $192.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Common Equity fell 37.67% year-over-year to $192.5 million; the trailing twelve-month figure through Jun 2026 stood at $192.5 million (down 37.67% YoY), and the FY2025 full-year result was $235.5 million, down 61.69% from the prior year.
• Common Equity fell to $192.5 million in Q2 2026 per ASPN's latest filing, from $213.5 million in the prior quarter.
• Across five years, Common Equity topped out at $614.7 million in Q4 2024 and bottomed at $164.8 million in Q2 2022.
• Historically, Common Equity has averaged $357.2 million across 5 years, with a median of $362.3 million in 2023.
• The sharpest annual moves came in 2022 and 2025: Common Equity surged 248.45% in 2022, then tumbled 61.69% in 2025.
• Over 5 years, Common Equity stood at $447.4 million in 2022, then increased by 9.08% to $488.1 million in 2023, then advanced by 25.95% to $614.7 million in 2024, then sank by 61.69% to $235.5 million in 2025, then decreased by 18.28% to $192.5 million in 2026.
• According to Business Quant data, Common Equity over the past three periods registered $192.5 million, $213.5 million, and $235.5 million for Q2 2026, Q1 2026, and Q4 2025 respectively.